CIK: 0001388551
Total reported value
$4.0M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | RZLT | Rezolute INC | Stock-Other | 72.60% | — | +21.61% | |
| 2 | GLD | Spdr Gold Shares | ETF-Commodities | 15.32% | +17.00% | +281.51% | |
| 3 | BRK-B | Berkshire Hathaway Inc-cl B | Stock-Other | 3.12% | +0.32% | +35.33% | |
| 4 | ELVN | Enliven Therapeutics INC | Stock-Other | 2.67% | — | — | |
| 5 | BRD1EUR | Mind Medicine Mindmed INC | Stock-Other | 2.24% | -4.91% | EXIT | |
| 6 | CMPX | Compass Therapeutics INC | Stock-Other | 1.15% | -3.70% | EXIT | |
| 7 | BCAX | Bicara Therapeutics INC | Stock-Other | 1.03% | — | — | |
| 8 | KYTX | Kyverna Therapeutics INC | Stock-Other | 0.72% | -0.09% | — | |
| 9 | LXEO | Lexeo Therapeutics INC | Stock-Other | 0.71% | -1.25% | -2.91% | |
| 10 | IKT | Inhibikase Therapeutics INC | Stock-Other | 0.32% | -0.17% | — | |
| 11 | CNTX | Context Therapeutics INC | Stock-Other | 0.12% | -0.63% | EXIT |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | GLD | Spdr Gold Shares | +8% | +281.51% | Add |
| 2 | ELVN | Enliven Therapeutics INC | +2.7% | NEW | New buy |
| 3 | CNTX | Context Therapeutics INC | -0.1% | — | Unchanged |
| 4 | KYTX | Kyverna Therapeutics INC | -0.2% | — | Unchanged |
| 5 | TORCEUR | Adicet Bio INC | -0.3% | EXIT | Sold out |
| 6 | IKT | Inhibikase Therapeutics INC | -0.4% | — | Unchanged |
| 7 | CMPX | Compass Therapeutics INC | -0.5% | — | Unchanged |
| 8 | LXEO | Lexeo Therapeutics INC | -0.5% | -2.91% | Trim |
| 9 | CRDF | Cardiff Oncology INC | -0.8% | EXIT | Sold out |
| 10 | BRD1EUR | Mind Medicine Mindmed INC | -1.7% | — | Unchanged |
| 11 | BRK-B | Berkshire Hathaway Inc-cl B | -1.8% | +35.33% | Add |
| 12 | BCAX | Bicara Therapeutics INC | -1.8% | — | Unchanged |
| 13 | RZLT | Rezolute INC | -2.7% | +21.61% | Add |